C
Carolyn Wester
Researcher at Harvard University
Publications - 52
Citations - 3121
Carolyn Wester is an academic researcher from Harvard University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 21, co-authored 37 publications receiving 2739 citations. Previous affiliations of Carolyn Wester include Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana
Roger L. Shapiro,Anthony Ogwu,Douglas Kitch,Shahin Lockman,Claire Moffat,Joseph Makhema,Sikhulile Moyo,Ibou Thior,Kenneth McIntosh,E. van Widenfelt,Jean Leidner,Kathleen M. Powis,Aida Asmelash,Esther Tumbare,S. Zwerski,U. Sharma,E. Handelsman,K. Mburu,Oluwemimo Jayeoba,E. Moko,Sajini Souda,E. Lubega,M. Akhtar,Carolyn Wester,R. Tuomola,W. Snowden,M. Martinez-Tristani,Loeto Mazhani,Myron Essex,Abstr Act +29 more
TL;DR: All regimens of HAART from pregnancy through 6 months post partum resulted in high rates of virologic suppression, with an overall rate of mother-to-child transmission of 1.1%.
Journal ArticleDOI
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Ibou Thior,Shahin Lockman,Laura M. Smeaton,Roger L. Shapiro,Carolyn Wester,S. Jody Heymann,Peter B. Gilbert,Lisa Stevens,Trevor Peter,Soyeon Kim,Erik van Widenfelt,Claire Moffat,Patrick Ndase,Peter Arimi,Poloko Kebaabetswe,Patson Mazonde,Joseph Makhema,Kenneth McIntosh,Vladimir Novitsky,Tun-Hou Lee,Richard Marlink,Stephen W. Lagakos,Max Essex,Mashi Study Team +23 more
TL;DR: Breastfeeding with zidovudine prophylaxis was not as effective as formula feeding in preventing postnatal HIV transmission, but was associated with a lower mortality rate at 7 months, and both strategies had comparable HIV-free survival at 18 months.
Journal ArticleDOI
Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine
Shahin Lockman,Roger L. Shapiro,Laura M. Smeaton,Carolyn Wester,Ibou Thior,Lisa Stevens,Fatima Chand,Joseph Makhema,Claire Moffat,Aida Asmelash,Patrick Ndase,Peter Arimi,Erik van Widenfelt,Loeto Mazhani,Vladimir Novitsky,Stephen W. Lagakos,Max Essex +16 more
TL;DR: The response to nevirapine-based antiretroviral treatment among women and infants who had previously been randomly assigned to a single, peripartum dose of ne virapine or placebo in a trial in Botswana involving the prevention of the transmission of HIV-1 from mother to child was studied.
Journal ArticleDOI
CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020.
TL;DR: CDC is augmenting previous guidance with two new recommendations: 1) hepatitis C screening at least once in a lifetime for all adults aged ≥18 years, except in settings where the prevalence of HCV infection is <0.1% and 2) Hepatitis C screening for all pregnant women during each pregnancy.
Journal ArticleDOI
Response to Antiretroviral Therapy After a Single, Peripartum Dose of Nevirapine
Shahin Lockman,Roger L. Shapiro,Laura M. Smeaton,Carolyn Wester,Ibou Thior,Lisa Stevens,Fatima Chand,Joseph Makhema,Claire Moffat,Aida Asmelash,Patrick Ndase,Peter Arimim Eri Van Widenfelt,Loeto Mazhani,Vladimir Novitsky,Stephen W. Lagakos,Max Essex +15 more
TL;DR: Women who received a single dose of nevirapine to prevent perinatal transmission of HIV-1 had higher rates of virologic failure with subsequent ne virapine-based antiretroviral therapy than did women without previous exposure to nevirAPine.